Boston Scientific Corporation ( BSX) - Key Metrics
BSX Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $3.57 | $0.45 | ? | ? |
| 2025Q3 | $3.42 | $0.51 | $0.91 | $0.78 |
| 2025Q2 | $3.42 | $0.54 | $0.87 | $0.74 |
| 2025Q1 | $3.16 | $0.46 | $0.37 | $0.24 |
BSX Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | 52.91 |
| 2025Q3 | ? | 47.90 |
| 2025Q2 | ? | 50.06 |
| 2025Q1 | ? | 55.27 |
BSX Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | 0.72% | ? |
| 2025Q3 | 0.80% | ? |
| 2025Q2 | 0.69% | ? |
| 2025Q1 | 0.24% | ? |
BSX
Price: $44.25
52 week price:
Payout Ratio Range:
Earnings Per Share: 2.39 USD
P/E Ratio: 25.08
Exchange: NYQ
Sector: Healthcare
Industry: Medical Devices
Country: United States
Volume: 13.0 million
Ebitda: 425.0 millionMarket Capitalization: 67.1 billion